Najib Maslouh has more than 25 years of CMC experience in all stages of peptide therapeutics development, from preclinical and clinical phases to registration and commercialization. Known to create value by optimizing all aspects of peptide synthesis, yielding sound, state-of-the-art manufacturing processes that are designed for reliable scale up. Current focus and interest is on peptide biochemistry, cosmeceuticals, sustainable manufacturing processes (green chemistry) and helping  biotechs develop peptides to treat and ultimately cure diseases. Najib holds the position of COO at UpTides and oversees the company's pipeline. Prior to that he founded ConsulTide, a CMC consulting company specialized in supporting biopharmaceutical companies in the development and commercialization of novel peptide therapeutics or peptide generics. Prior to that Najib was VP of manufacturing and technical operations at Apellis (APLS) and contributed significantly to the approval of EMPAVELI®️ and SYFOVRE®️ for the treatment of PNH and GA, respectively. Prior to that Najib was overseeing the US manufacturing sites of Bachem (BANB.SW), the leading CDMO for peptides. As site head he was responsible for all operations, including R&D, GMP manufacturing, quality control, quality assurance, materials and facility management. Najib holds a master's and a Ph.D in organic chemistry, both from the University of Innsbruck, Austria.